ResMed
627 hedge funds and large institutions have $17.3B invested in ResMed in 2020 Q3 according to their latest regulatory filings, with 95 funds opening new positions, 217 increasing their positions, 227 reducing their positions, and 49 closing their positions.
94% more first-time investments, than exits
New positions opened: 95 | Existing positions closed: 49
8% more funds holding
Funds holding: 583 → 627 (+44)
4% less repeat investments, than reductions
Existing positions increased: 217 | Existing positions reduced: 227
1.2% less ownership
Funds ownership: 70.76% → 69.56% (-1.2%)
12% less capital invested
Capital invested by funds: $19.6B → $17.3B (-$2.37B)
26% less call options, than puts
Call options by funds: $60.1M | Put options by funds: $80.8M
50% less funds holding in top 10
Funds holding in top 10: 14 → 7 (-7)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State of Tennessee, Department of Treasury
Nashville,
Tennessee
|
+$42.6M |
| 2 |
JP Morgan Chase
New York
|
+$41.2M |
| 3 |
WCM Investment Management
Laguna Beach,
California
|
+$41M |
| 4 |
MWNA
Marshall Wace North America
New York
|
+$40.1M |
| 5 |
Janus Henderson Group
London,
|
+$29.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$261M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$132M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$64.3M |
| 4 |
CTA
Carillon Tower Advisers
St. Petersburg,
Florida
|
-$62M |
| 5 |
UBS AM
Chicago,
Illinois
|
-$26.7M |
RMD Hedge Fund Activity: Q3 2020 in Review
627 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in ResMed (RMD) for Q3 2020, worth a combined $17.3B — down 12% from $19.6B a quarter earlier.
Buyers outnumbered sellers: 95 funds opened new RMD positions and 49 closed out — a net gain of 46 holders — while 217 added to existing stakes and 227 trimmed.
The largest buyer was State of Tennessee, Department of Treasury, adding an estimated $42.6M. The largest seller was Baillie Gifford & Co, cutting an estimated $261M.
- 627 institutional investors held ResMed (RMD) as of Q3 2020, up from 583 in Q2 2020.
- Funds reported $17.3B of ResMed stock for Q3 2020, down 12% quarter-over-quarter.
- 95 funds opened new ResMed positions in Q3 2020 and 49 closed out, a net change of +46 holders.
- The largest ResMed buyer in Q3 2020 was State of Tennessee, Department of Treasury, an estimated $42.6M added.
- The largest ResMed seller in Q3 2020 was Baillie Gifford & Co, an estimated $261M sold.
Based on aggregated 13F filings for Q3 2020.